Glaxo, Danone Probe Highlights Challenges in China

Glaxo, Danone Probe Highlights Challenges in China Play

July 3 (Bloomberg) -- China’s probes of GlaxoSmithKline and Danone highlight challenges for foreign companies in a market where they may be a bigger “prize” for regulators seeking to allay concerns that medicines and foods are unsafe. Stephen Engle reports on Bloomberg Television's "First Up." (Source: Bloomberg)

blog comments powered by Disqus